申请人:Endo Laboratories
公开号:US04107165A1
公开(公告)日:1978-08-15
Novel alkylenetris- and alkylenetetrakis-[1,2,3,4-tetrahydroisoquinoline] and -[3,4-dihydroisoquinoline] compounds, the pharmaceutically acceptable acid addition salts thereof and compositions containing such substances have been found useful for inhibiting the formation of blood clots in mammals and/or dissolving blood clots in mammals after they have been formed.
已发现,新颖的烷基三和烷基四-[1,2,3,4-四氢异喹啉]和-[3,4-二氢异喹啉]化合物,其药学上可接受的酸盐以及含有这些物质的组合物,对于抑制哺乳动物体内血栓的形成和/或溶解已经形成的血栓具有实用价值。